Navigation Links
Isis Reports Strong Financial Results and Highlights for Fiscal Year 2008
Date:2/25/2009

ging study in heterozygous FH subjects and long-term dosing data in FH patients exposed to mipomersen from three to 23 months.
  • Publishing preclinical data showing that lowering of apoB-100 resulted in significant reduction of atherosclerotic plaques in murine models of atherosclerosis.
  • In addition, Isis and its partners showed encouraging clinical results in a broad range of diseases including,

    • Encouraging Phase 2 data of OGX-011 in prostate cancer patients showing survival advantage, durable reductions in pain, and declines in PSA.
    • Positive Phase 2 results showing that ATL/TV1102 demonstrated a highly significant effect on disease activity in patients with multiple sclerosis.
    • Interim data from an ongoing Phase 1 study showing that iCo-007 appears to be well tolerated in patients with diffuse diabetic macular edema.

    Isis broadened its pipeline with the addition of new drugs that Isis' partners are developing including,

    • An antisense drug that targets PCSK9, BMS-PCSK9Rx.
    • An antisense drug for the local treatment of fibrosis and scarring, EXC001.
    • A novel aminoglycoside drug, ACHN-490, which Achaogen is developing to treat bacterial infections.

    Isis' pipeline matured with the initiation of clinical trials in multiple drugs including,

    • ISIS-CRPRx to treat coronary artery disease, inflammation and end-stage renal disease.
    • ISIS-SGLT2Rx to treat type 2 diabetes.
    • AIR645 to treat asthma.
    • LY2181308 to treat cancer.

    Corporate Highlights

    Isis continued to execute its successful business strategy by monetizing key assets with partners to continue the development and commercialization of the assets with
    '/>"/>

    SOURCE Isis Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine news :

    1. Lehigh Valley-Based PPO, Valley Preferred, Reports Marked Improvement in Disease Management & Wellness Outcomes
    2. Valeant Pharmaceuticals Reports Fourth Quarter and Full Year Financial Results
    3. Symmetry Medical Reports Fourth Quarter and Full Year 2008 Financial Results
    4. ev3 Inc. Reports 2008 Fourth Quarter and Full-Year Financial Results and 2009 Guidance
    5. Update: Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
    6. HealthSouth Reports Results for Fourth Quarter Ended December 31, 2008
    7. Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2008 Financial Results
    8. Solta Medical Reports Fourth Quarter and Full Year 2008 Results
    9. 1 in 10 Ex-NFL Players Used Steroids, Poll Reports
    10. ISTA Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
    11. Nyer Medical Group, Inc. Reports Revenues of $19.0 Million for the Quarter Ended December 31, 2008
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2015)... ... July 30, 2015 , ... World Patent Marketing, a ... app invention that can help people during emergencies. , "The worldwide mobile health ... Creative Director of World Patent Marketing. "Currently, there are about 97,000 mobile health ...
    (Date:7/30/2015)... ... 2015 , ... In an effort to provide the twenty four hour continuous ... in his practice. , The decision will also allow him to spend more time ... transferring his in-patient admissions to the hospitalists at East Liverpool City Hospital.Dr. Aggarwal has ...
    (Date:7/30/2015)... ... July 30, 2015 , ... In a meaningful ritual intended ... Palms Drug Addiction Treatment Center have created an addiction graveyard. Sharing this with the ... most beloved residents, Rocky Hudson . Hudson (1945-2015) fell in love with the ...
    (Date:7/30/2015)... ... 30, 2015 , ... Google recently announced that it will be disclosing any ... in a June 8, 2015 article published by Nasdaq , the powerful tech ... by its computer-driven cars, which such industry players as Tesla CEO Elon Musk believe ...
    (Date:7/30/2015)... ... July 30, 2015 , ... 24/7 Care At Home, a ... San Bernardino, recently announced that the Centers for Medicare and Medicaid (CMS) have awarded ... health care providers. 24/7 Care At Home’s agency is one of three top Orange ...
    Breaking Medicine News(10 mins):Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 2Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 3Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 4Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 5Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 3Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 2Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 3Health News:24/7 Care At Home Earns a 5-Star Rating from the Centers for Medicare and Medicaid (CMS) 2
    ... women need screening as much as younger ones, , , ... should continue for women older than 50 -- even ... they have a similar level of risk as younger ... there,s little benefit in repeating smear tests in women ...
    ... As federal policymakers pursue healthcare reform this year, the ... prevention will be critically evaluated. As part of ... North America,s top medical schools will host scientists from ... the area of integrative medicine. The Consortium ...
    ... genetic study conducted through Mayo Clinic has identified ... European ancestry, according to a recent issue of ... , Research findings indicate that alcohol dependence ... variations associated with this illness remain unknown. Animal ...
    ... Holistic Addiction Treatment has added the use of Mild Hyperbarics to drug ... Scotland and Russia, mild hyperbarics is not generally associated with drug and ... alcohol treatment and recovery services that meet the needs of the person ... ...
    ... finds vets at higher risk of aggressive recurrence only ... News) -- U.S. male military veterans exposed to the ... recurrence of prostate cancer, a new study finds. , ... cancerous prostates. Of those, the 206 men who,d been ...
    ... Health Ministry Official shows programs funded by the Global Fund and President,s ... , ... Washington, DC (PRWEB) April 23, 2009 -- At a Congressional ... discussed the current state of malaria in Rwanda and how ...
    Cached Medicine News:Health News:Don't Lower Age for Cervical Cancer Test, Study Urges 2Health News:Advancements in Integrative Medicine Research to Be Evaluated by Scientists From Leading International Academic Health Centers 2Health News:Mayo clinic study finds gene bringing together animal and human research in alcoholism 2Health News:G & G Holistic Addiction Treatment Uses Innovative Use of Oxygen Therapy Which Restores Mind and Body in Drug Rehab 2Health News:G & G Holistic Addiction Treatment Uses Innovative Use of Oxygen Therapy Which Restores Mind and Body in Drug Rehab 3Health News:Agent Orange Exposure Tied to Prostate Cancer Return 2Health News:A View from Rwanda: Congressional Briefing Highlights Impact of U.S. funded Anti-Malaria Programs 2Health News:A View from Rwanda: Congressional Briefing Highlights Impact of U.S. funded Anti-Malaria Programs 3
    (Date:7/30/2015)... DIEGO , July 30, 2015  Tandem ... medical device company and manufacturer of the t:slim® ... has entered into non-exclusive Development Agreements with Dexcom, ... Tandem insulin pumps with the Dexcom G5 and ... "Integrating Tandem,s next generation pump platform with Dexcom,s ...
    (Date:7/30/2015)... and VANCOUVER , July ... ) announced today that it will report its second ... Company management will host a conference call and live ... overview of financial results, clinical development programs and a ... webcast, log on to the Investor Relations page of ...
    (Date:7/30/2015)... , July 30, 2015 Tianyin Pharmaceutical Inc. ... company that specializes in the patented biopharmaceutical, modernized traditional ... (API), provided updates regarding the notice it received on ... "Exchange") indicating that the Company was below certain of ... Sections 134 and 1101 of the NYSE MKT Company ...
    Breaking Medicine Technology:Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2
    ... LEIDEN, Netherlands, March 8, 2011 Johnson & Johnson (NYSE: ... CRXL ; Swiss Exchange: CRX) today announced that ... Subsequent Offering Period), Johnson & Johnson has acquired 98.89% ... treasury shares held by Crucell) and 98.93% of the issued ...
    ... 2011 Sequenom, Inc. (Nasdaq: SQNM ) today ... year ended December 31, 2010. (Logo:   http://photos.prnewswire.com/prnh/20040415/SQNMLOGO ... Total revenue for the fourth quarter of 2010 grew 28% ... quarter of 2009. The increase in revenue compared to the ...
    Cached Medicine Technology:Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs 2Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs 3Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs 4Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs 5Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs 6Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs 7Sequenom Reports Fourth Quarter and Full Year 2010 Financial Results 2Sequenom Reports Fourth Quarter and Full Year 2010 Financial Results 3Sequenom Reports Fourth Quarter and Full Year 2010 Financial Results 4Sequenom Reports Fourth Quarter and Full Year 2010 Financial Results 5Sequenom Reports Fourth Quarter and Full Year 2010 Financial Results 6Sequenom Reports Fourth Quarter and Full Year 2010 Financial Results 7Sequenom Reports Fourth Quarter and Full Year 2010 Financial Results 8Sequenom Reports Fourth Quarter and Full Year 2010 Financial Results 9
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: